|
The account reported finding chloraprep preactivated, and the customer reported that 2 ea had broken chloraprep.A photo was received for the investigation; the up-close photo was of the chloraprep and some components, with no other pack contents visible, and orange staining on the chloraprep packaging and a partially orange internal sponge were observed.Based on the investigation and photo evaluation, the reported issue was confirmed.The placement of the chloraprep in the pack was reviewed and found to be in a location that provides adequate protection from pre-activation; it is possible that the activation point may have inadvertently been compressed, causing the component to activate at some point during transit or storage, and the division will monitor this issue for trending purposes.There were no reports of death, serious injury, medical intervention, or follow up care.It has been determined that the reported event could cause or contribute to serious injury if it were to occur again.In an abundance of caution, this is a reportable event.If additional information becomes available this report will be reopened and reevaluated.This medical device report (mdr) is being submitted as part of retrospective review activities, which include review of historical data in accordance with regulations at 21 cfr part 803.The information included in this mdr reflects the information reasonably known to the manufacturer at the time of this retrospective review and submission.
|